Literature DB >> 9077526

Glucose effectiveness assessed under dynamic and steady state conditions. Comparability of uptake versus production components.

M Ader1, T C Ni, R N Bergman.   

Abstract

Glucose tolerance is determined by both insulin action and insulin-independent effects, or "glucose effectiveness," which includes glucose-mediated stimulation of glucose uptake (Rd) and suppression of hepatic glucose output (HGO). Despite its importance to tolerance, controversy surrounds accurate assessment of glucose effectiveness. Furthermore, the relative contributions of glucose's actions on Rd and HGO under steady state and dynamic conditions are unclear. We performed hyperglycemic clamps and intravenous glucose tolerance tests in eight normal dogs, and assessed glucose effectiveness by two independent methods. During clamps, glucose was raised to three successive 90-min hyperglycemic plateaus by variable labeled glucose infusion rate; glucose effectiveness (GE) was quantified as the slope of the dose-response relationship between steady state glucose and glucose infusion rate (GE[CLAMP(total)]), Rd (GE[CLAMP(uptake)]) or HGO (GE[CLAMP(HGO)]). During intravenous glucose tolerance tests, tritiated glucose (1.2 microCi/kg) was injected with cold glucose (0.3 g/kg); glucose and tracer dynamics were analyzed using a two-compartment model of glucose kinetics to obtain Rd and HGO components of glucose effectiveness. All experiments were performed during somatostatin inhibition of islet secretion, and basal insulin and glucagon replacement. During clamps, Rd rose from basal (2.54+/-0.20) to 3.95+/-0.54, 6.76+/-1.21, and 9.48+/-1.27 mg/min per kg during stepwise hyperglycemia; conversely, HGO declined to 2.06+/-0.17, 1.17+/-0.19, and 0.52+/-0.33 mg/min per kg. Clamp-based glucose effectiveness was 0.0451+/-0.0061, 0.0337+/-0.0060, and 0.0102+/-0.0009 dl/min per kg for GE[CLAMP(total)], GE[CLAMP(uptake)], and GE[CLAMP(HGO)], respectively. Glucose's action on Rd dominated overall glucose effectiveness (72.2+/-3.3% of total), a result virtually identical to that obtained during intravenous glucose tolerance tests (71.6+/-6.1% of total). Both methods yielded similar estimates of glucose effectiveness. These results provide strong support that glucose effectiveness can be reliably estimated, and that glucose-stimulated Rd is the dominant component during both steady state and dynamic conditions.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9077526      PMCID: PMC507932          DOI: 10.1172/JCI119275

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  45 in total

Review 1.  Transport of glucose from blood to brain.

Authors:  H Lund-Andersen
Journal:  Physiol Rev       Date:  1979-04       Impact factor: 37.312

2.  Insulin control of glucose metabolism in man: a new kinetic analysis.

Authors:  P A Insel; J E Liljenquist; J D Tobin; R S Sherwin; P Watkins; R Andres; M Berman
Journal:  J Clin Invest       Date:  1975-05       Impact factor: 14.808

3.  Reduced glucose effectiveness associated with reduced insulin release: an artifact of the minimal-model method.

Authors:  D T Finegood; D Tzur
Journal:  Am J Physiol       Date:  1996-09

4.  Quantitative estimation of insulin sensitivity.

Authors:  R N Bergman; Y Z Ider; C R Bowden; C Cobelli
Journal:  Am J Physiol       Date:  1979-06

5.  Metabolic characteristics of African descendants: a comparative study of African-Americans and Ghanaian immigrants using minimal model analysis.

Authors:  K Osei; D P Schuster
Journal:  Diabetologia       Date:  1995-09       Impact factor: 10.122

6.  Assessment of insulin action and glucose effectiveness in diabetic and nondiabetic humans.

Authors:  A A Alzaid; S F Dinneen; D J Turk; A Caumo; C Cobelli; R A Rizza
Journal:  J Clin Invest       Date:  1994-12       Impact factor: 14.808

7.  Free fatty acid as a link in the regulation of hepatic glucose output by peripheral insulin.

Authors:  K Rebrin; G M Steil; L Getty; R N Bergman
Journal:  Diabetes       Date:  1995-09       Impact factor: 9.461

8.  Nandrolone, a 19-nortestosterone, enhances insulin-independent glucose uptake in normal men.

Authors:  C J Hobbs; R E Jones; S R Plymate
Journal:  J Clin Endocrinol Metab       Date:  1996-04       Impact factor: 5.958

9.  Insulinopenia and hyperglycemia influence the in vivo partitioning of GE and SI.

Authors:  M J Christopher; C Rantzau; G M Ward; F P Alford
Journal:  Am J Physiol       Date:  1995-03

10.  Insulin sensitivity accounts for glucose and lactate kinetics after intravenous glucose injection.

Authors:  R M Watanabe; J Lovejoy; G M Steil; M DiGirolamo; R N Bergman
Journal:  Diabetes       Date:  1995-08       Impact factor: 9.461

View more
  19 in total

1.  Effects of Interrupting Children's Sedentary Behaviors With Activity on Metabolic Function: A Randomized Trial.

Authors:  Britni R Belcher; David Berrigan; Alexia Papachristopoulou; Sheila M Brady; Shanna B Bernstein; Robert J Brychta; Jacob D Hattenbach; Ira L Tigner; Amber B Courville; Bart E Drinkard; Kevin P Smith; Douglas R Rosing; Pamela L Wolters; Kong Y Chen; Jack A Yanovski
Journal:  J Clin Endocrinol Metab       Date:  2015-08-27       Impact factor: 5.958

2.  Parenteral glucose and glucose control in the critically ill: a kinetic appraisal.

Authors:  Roman Hovorka; Jeremy Cordingley
Journal:  J Diabetes Sci Technol       Date:  2007-05

3.  Decrease of FGF19 contributes to the increase of fasting glucose in human in an insulin-independent manner.

Authors:  J Zhang; H Li; N Bai; Y Xu; Q Song; L Zhang; G Wu; S Chen; X Hou; C Wang; L Wei; A Xu; Q Fang; W Jia
Journal:  J Endocrinol Invest       Date:  2019-03-09       Impact factor: 4.256

Review 4.  The forgotten role of glucose effectiveness in the regulation of glucose tolerance.

Authors:  Simmi Dube; Isabel Errazuriz-Cruzat; Ananda Basu; Rita Basu
Journal:  Curr Diab Rep       Date:  2015-06       Impact factor: 4.810

Review 5.  Menopausal Hormone Therapy and Type 2 Diabetes Prevention: Evidence, Mechanisms, and Clinical Implications.

Authors:  Franck Mauvais-Jarvis; JoAnn E Manson; John C Stevenson; Vivian A Fonseca
Journal:  Endocr Rev       Date:  2017-06-01       Impact factor: 19.871

6.  Regulation of endogenous glucose production by glucose per se is impaired in type 2 diabetes mellitus.

Authors:  M Mevorach; A Giacca; Y Aharon; M Hawkins; H Shamoon; L Rossetti
Journal:  J Clin Invest       Date:  1998-08-15       Impact factor: 14.808

7.  Portal glucose infusion-glucose clamp measures hepatic influence on postprandial systemic glucose appearance as well as whole body glucose disposal.

Authors:  Dan Zheng; Viorica Ionut; Vahe Mooradian; Darko Stefanovski; Richard N Bergman
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-11-24       Impact factor: 4.310

8.  Evidence for pancreatic beta-cell dysfunction in brothers of women with polycystic ovary syndrome.

Authors:  Susan Sam; Yeon-Ah Sung; Richard S Legro; Andrea Dunaif
Journal:  Metabolism       Date:  2008-01       Impact factor: 8.694

9.  Quantitative path to deep phenotyping: Possible importance of reduced hepatic insulin degradation to type 2 diabetes mellitus pathogenesis.

Authors:  Richard N Bergman; Francesca Piccinini; Isaac Asare Bediako; Morvarid Kabir; Cathryn Kolka; David Polidori; Marilyn Ader
Journal:  J Diabetes       Date:  2018-07-02       Impact factor: 4.006

Review 10.  Lipid composition of cell membranes and its relevance in type 2 diabetes mellitus.

Authors:  Rob N M Weijers
Journal:  Curr Diabetes Rev       Date:  2012-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.